Biostats and epidemiology Flashcards
Definition of type 1 error (alpha error)
Rejecting the null hypothesis when it is really true
Definition of a type 2 error (beta error)
Not rejecting the null hypothesis when it is really false
Ways to increase statistical power
- Increase the sample size (most common)
- Increase the expected effect size
- Increase precision of measurement
Use of the t-test
Comparing the means of two groups from a single nominal variable, using means from an Interval variable to see whether the groups are different
Use of one-way ANOVA
Compares means of many groups (2 or more) of a single nominal variable using an interval variable
Use of chi squared
Tests to see whether two nominal variables (not mean) are independent
Infectious diseases that require mandatory reporting to the local Public Health Department, who will inform the CDC
“Salas siente comezón, grita y chilla al horinar”
- Chlamydia
- Gonorrhea
- Chicken pox
- AIDS
- Syphilis
- Salmonella
- Hepatitis A and B
- Tuberculosis
- Lyme disease
- Other: pertussis, legionnaires, mumps, rubella and measles
Coverage of Medicare
- Ambulance transport
- Dialysis
- Speech and occupational therapy
Data analysis test used in cross-sectional studies
Chi-squared
Data analysis test used in case-control studies
Odds ratio
Data analysis test used in cohort studies
Relative risk
Describe the sample size, data evaluated, and duration of phase 1 clinical trials
- Sample size: 20 to 100 (healthy)
- Data evaluated: safety, toxicity, pharmacokinetics/pharmacodynamics, adverse effects
- Duration: 1 to 30 days
“Is it SAFE?”
Describe the sample size, data evaluated, and duration of phase 2 clinical trials
- Sample size: 100 to 300 (disease)
- Data evaluated: dose, tolerability, efficacy, adverse effects
- Duration: months
“Does it WORK?”
Describe the sample size, data evaluated, and duration of phase 3 clinical trials
- Sample size: 100s to 1000s
- Data evaluated: compares the new treatment to the current standard of care
- Duration: months to years
“Any IMPROVEMENT?”
Describe the sample size, data evaluated, and duration of phase 4 clinical trials
- Sample size: 1000s
- Data evaluated: epidemiology, postmarketing surveillance, common and rare side effects
- Duration: years
“MARKET”
Define sensitivity
Proportion of truly diseased persons in the screened population who are identified as diseased by the screening test (“true positive rate”)
Define specificity
Proportion of truly disease-free persons who are identified as non-diseased by the screening test (“true negative rate”)
Define positive predictive value
Probability that a person with a positive test is a true positive
Define negative predictive value
Probability of no disease in a person with a negative test
Define accuracy
Degree to which a measurement, or an estimate based on measurements, represents the true value of the attribute that is being measured
Formula for odds ratio
OR = AD/BC
*La probabilidad de que los que estuvieron expuestos desarrollen la enfermedad sobre la probabilidad de que los que no estuvieron expuestos desarrollen la enfermedad ((A/B)/(C/D))
Formula for relative risk
RR = (A/A+B)/(C/C+D)
*La incidencia de la enfermedad en los que estuvieron expuestos sobre la incidencia de la enfermedad sobre los que no estuvieron expuestos
Define the attributable risk
The difference in risk between exposed and unexposed groups, or the proportion of disease occurrences that are attributable to the exposure
Formula of attributable risk
AR = (A/A+B) - (C/C+D)
*La incidencia de la enfermedad en los que estuvieron expuestos menos la incidencia de la enfermedad en los que no estuvieron expuestos
Define a selection bias
When the sample is not representative (nonrandom smapling or treatment allocation of subjects)
Examples of selection biases
- Berkson bias
- Non-response bias
- Healthy worker effect